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Athletes are prone to cardiac arrhythmias, and sinus bra-dycardia is the most common rhythm disturbance.1 In the 
long term, this physiological adaptation can become pathologi-
cal because veteran athletes are more likely to have sinus node 
dysfunction and to need an electronic pacemaker implantation 
than nonathletes.2–4 In 2 rodent models of exercise training, we 
previously demonstrated that the training-induced bradycardia 
is predominantly the result of a downregulation of the key pace-
making ion channel HCN4 (hyperpolarization-activated cyclic 
nucleotide gated channel 4) and the corresponding ionic current 
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Rationale: Downregulation of the pacemaking ion channel, HCN4 (hyperpolarization-activated cyclic nucleotide 
gated channel 4), and the corresponding ionic current, If, underlies exercise training–induced sinus bradycardia in 
rodents. If this occurs in humans, it could explain the increased incidence of bradyarrhythmias in veteran athletes, 
and it will be important to understand the underlying processes.
Objective: To test the role of HCN4 in the training-induced bradycardia in human athletes and investigate the role 
of microRNAs (miRs) in the repression of HCN4.
Methods and Results: As in rodents, the intrinsic heart rate was significantly lower in human athletes than 
in nonathletes, and in all subjects, the rate-lowering effect of the HCN selective blocker, ivabradine, was 
significantly correlated with the intrinsic heart rate, consistent with HCN repression in athletes. Next-generation 
sequencing and quantitative real-time reverse transcription polymerase chain reaction showed remodeling of 
miRs in the sinus node of swim-trained mice. Computational predictions highlighted a prominent role for miR-
423-5p. Interaction between miR-423-5p and HCN4 was confirmed by a dose-dependent reduction in HCN4 
3′-untranslated region luciferase reporter activity on cotransfection with precursor miR-423-5p (abolished by 
mutation of predicted recognition elements). Knockdown of miR-423-5p with anti-miR-423-5p reversed training-
induced bradycardia via rescue of HCN4 and If. Further experiments showed that in the sinus node of swim-
trained mice, upregulation of miR-423-5p (intronic miR) and its host gene, NSRP1, is driven by an upregulation 
of the transcription factor Nkx2.5.
Conclusions: HCN remodeling likely occurs in human athletes, as well as in rodent models. miR-423-5p contributes 
to training-induced bradycardia by targeting HCN4. This work presents the first evidence of miR control of 
HCN4 and heart rate. miR-423-5p could be a therapeutic target for pathological sinus node dysfunction in veteran 
athletes.  (Circ Res. 2017;121:1058-1068. DOI: 10.1161/CIRCRESAHA.117.311607.)
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(funny current, If) in the sinus node.5 We now report the first 
evidence that HCN4 and If downregulation is also responsible 
for training-induced sinus bradycardia in human athletes. What 
is responsible for the downregulation of HCN4 in the athlete? 
Despite its fundamental importance, regulation of HCN4 in 
health and disease is poorly understood. MicroRNAs (miRs) 
have been shown to play pivotal roles in cardiac remodeling in a 
variety of settings by post-transcriptional silencing of genes.6–9 
Some miRs have been implicated in ion channel remodel-
ing.7–9 We report here that the downregulation of HCN4 and If 
in trained mice is the result of an upregulation of miR-423-5p 
in the sinus node, and the training-induced bradycardia can be 
reversed by targeting the miR-dependent HCN4 remodeling.
Editorial, see p 1027 
Meet the First Author, see p 1022
Methods
A 3-lead ECG was recorded from male volunteers aged 18 to 30 years: 
8 competitive endurance athletes and 10 sedentary age-matched (con-
trol) subjects. The heart rate was measured before and after complete 
autonomic blockade (achieved by intravenous injection of 0.04 mg/
kg atropine and 0.2 mg/kg propranolol followed by top-up doses). 
After complete autonomic blockade, 7.5 mg ivabradine was admin-
istered orally, and the change in heart rate was recorded and used 
as a measure of the involvement of If in pacemaking. Ten-week-old 
C57BL/6J mice were trained by swimming for 60 minutes twice dai-
ly for 28 days.5 miR, mRNA, and protein expression in sinus node 
biopsies was measured by next-generation sequencing, quantitative 
real-time reverse transcription polymerase chain reaction (qPCR), 
Western blot, and high-resolution mass spectrometry. Computational 
predictions, luciferase reporter gene assays, and in vitro overexpres-
sion studies were used to identify miRs and transcription factors 
capable of regulating expression. The role of a candidate miR in the 
training-induced bradycardia was tested in vivo by administering an 
appropriate cholesterol-conjugated anti-miR.6 ECG recording, in vi-
tro tissue electrophysiology, Western blot, sinus node cell isolation, 
and whole-cell patch clamp were used to characterize the mice and 
study HCN4 and If remodeling. Statistically significant differences 
were determined using an appropriate test; P<0.05 was regarded as 
significant. In figures, bar charts show means±SEM. Further details 
of methods are available in the Online Data Supplement.
Results
Evidence of If Remodeling in Human Athletes
Experiments were conducted on groups of human male non-
athletes (n=10) and athletes (n=8). The characteristics of the 2 
groups are given in Online Table I. As expected, the maximum 
O2 uptake (VO2max, a measure of fitness) of the athletes was 
significantly higher than that of the nonathletes (Figure 1A). 
Figure 1B shows the resting heart rate under baseline condi-
tions of the 2 groups of subjects; as expected, the heart rate of 
the athletes was significantly lower. It is still widely thought 
that the training-induced bradycardia is the result of an in-
crease in vagal tone based on reported increases in heart rate 
variability in athletes10; heart rate variability is considered a 
measure of autonomic tone. However, we have recently shown 
that heart rate variability is primarily determined by heart rate 
and not autonomic tone.11 In the present study, neither uncor-
rected standard deviation of normal to normal beats (a measure 
of heart rate variability) or standard deviation of normal to nor-
mal beats corrected for changes in heart rate11 was increased in 
the athletes (Online Table I). Figure 1B also shows the intrinsic 
heart rate after complete autonomic blockade in the 2 groups 
of subjects. Autonomic blockade was achieved by intravenous 
injection of 0.2 mg/kg propranolol and 0.04 mg/kg atropine, 
doses that have previously been demonstrated to cause com-
plete autonomic blockade in human subjects.12,13 The intrinsic 
heart rate after complete autonomic blockade in the nonathletes 
was 97.9±2.6 bpm, similar to the value reported by Jose and 
Collison14 of 105.6±0.6 bpm from 139 untrained male subjects 
20 to 30 years of age. This suggests that complete autonomic 
blockade was achieved (see Online Data Supplement for further 
discussion).15 Furthermore, heart rate variability was almost 
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HCN4 hyperpolarization-activated cyclic nucleotide gated channel 4
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microRNA miR–microribonucleic acid





• Athletes have a slow resting heart rate, that is, sinus bradycardia, 
and in veteran athletes, this can necessitate electronic pacemaker 
implantation.
• We have previously shown that a downregulation of the key pacemak-
ing ion channel, HCN4 (hyperpolarization-activated cyclic nucleotide 
gated channel 4), and the corresponding ionic current (funny current or 
If) in the sinus node underlies the sinus bradycardia in rodent models 
of exercise training.
What New Information Does This Article Contribute?
• In human athletes, evidence suggests that I
f
 is also downregulated.
• In the mouse, evidence suggests that the downregulation of HCN4 and I
f
 
is the result of an upregulation of Nkx2.5 and, consequently, miR-423-5p.
• In the mouse, the training-induced bradycardia is reversed by blocking 
the action of miR-423-5p.
In exercise-trained rodents, we previously attributed the sinus bra-
dycardia to downregulation of I
f
. Now we show, in human athletes, 
the intrinsic heart rate (measured after autonomic blockade) is 
slower, and this is correlated with a smaller response to ivabradine. 
In the exercise-trained mouse, we then identified an upregulation 
of miR-423-5p (regulatory microRNA) and Nkx2.5 (transcription 
factor)—further experiments showed that Nkx2.5 can upregulate 
miR-423-5p and miR-423-5p can downregulate HCN4. Blocking 
miR-423-5p with an anti-miR reversed the training-induced sinus 
bradycardia. For the first time, this suggests that there is a downreg-
ulation of I
f
 in human athletes and identifies the pathway involved.
1060  Circulation Research  October 13, 2017
completely eliminated after autonomic blockade: uncorrected 
standard deviation of normal to normal beats was reduced by 
94%, corrected standard deviation of normal to normal beats 
was reduced by 90%, and high-frequency spectral heart rate 
variability was reduced by >99% (Figure 1C). This is consis-
tent with complete autonomic blockade. Figure 1B shows that 
there was a significant bradycardia in the athletes (as compared 
with the nonathletes) after complete autonomic blockade, as 
well as under baseline conditions (the relative bradycardia was 
larger after complete autonomic blockade). We conclude that 
the bradycardia cannot be attributed to the autonomic nervous 
system, although we appreciate that others have concluded that 
it is the result of high vagal tone (see Online Data Supplement 
for further discussion). Figure 1D shows that the intrinsic heart 
Figure 1. Evidence of a role for HCN4 (hyperpolarization-activated cyclic nucleotide gated channel 4) in the resting bradycardia 
in human athletes. A, VO2max of sedentary human subjects and human athletes (n=7/8). B, Heart rates measured under baseline 
conditions and after complete autonomic blockade of sedentary human subjects and human athletes (n=10/8). C, Complete autonomic 
blockade abolishes heart rate variability. Left, Examples traces of RR interval under baseline conditions and after complete autonomic 
blockade. Right, Spectral analyses of corresponding RR interval plots demonstrating near-abolition of high-frequency (HF) heart 
rate variability after autonomic blockade (note difference in y axis scale). D, Relationship between the intrinsic heart rate measured 
after complete autonomic blockade and VO2max in sedentary human subjects and human athletes (n=7/8). E, Relationship between 
ivabradine-induced decrease in heart rate and the intrinsic heart rate measured after complete autonomic blockade in sedentary human 
subjects and human athletes (n=10/8). In D and E, data fit by linear regression; best fit line, 95% confidence limits, and R2 and P values 
shown. PSD indicates power spectral density; and SDNN, standard deviation of normal to normal beats.
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Figure 2. If remodeling in training-induced bradycardia is accompanied by dysregulation of miRs. A, Heart rates of sedentary and 
trained mice measured in vivo in conscious animals (n=5/9) and in vitro in isolated sinus node preparations (n=6/6). B, Expression of 
HCN4 (hyperpolarization-activated cyclic nucleotide gated channel 4) mRNA in sinus node of sedentary and trained mice (n=5/5). C, 
Current–voltage relationships for If recorded from single sinus node cells from sedentary (n=47 cells/5 mice) and trained (n=58 cells/4 
mice) mice. D, Relationship between ivabradine-induced decrease in heart rate and the intrinsic heart rate measured in vivo after 
complete autonomic blockade in sedentary and trained mice (n=8/10). Data fit by linear regression; best fit line, 95% confidence limits, 
and R2 and P values are shown. E, Significant (as determined by DeSeq) training-induced changes in miR expression (Continued )
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rate of the nonathletes and athletes is significantly correlated 
with the fitness of the subjects as measured by the VO2max. 
Figure 1E shows a significant correlation between the heart 
rate lowering effect of oral ivabradine (blocks HCN4 and If) 
and the intrinsic heart rate of the nonathletes and athletes: sub-
jects with a lower intrinsic heart rate (generally athletes) had 
a blunted response to ivabradine. This suggests that in the hu-
man athlete, there is a downregulation of HCN4 and If, and this 
could be the cause (or at least a key contributing cause) of the 
training-induced bradycardia.
Training-Induced Downregulation of HCN4 and 
Dysregulation of miRs
After swim-training for 4 weeks in the mouse, there was a sig-
nificant bradycardia both in vivo and in the isolated sinus node 
(Figure 2A). This was confirmed by intracellular action poten-
tial recording from the isolated sinus node; the bradycardia was 
accompanied by a small positive shift of the maximum diastolic 
potential and prolongation of the action potential (Online Table 
II). The 2 main pacemaking mechanisms are the membrane and 
Ca2+ clocks.16 Although the main Ca2+ clock transcripts in the 
sinus node were unaffected by training (Online Figure I), the 
transcript for HCN4 (the main component of the membrane 
clock16) was significantly downregulated in the sinus node af-
ter training (Figure 2B). As expected, this was accompanied by 
a reduction of If over a wide potential range in isolated sinus 
node cells from trained mice (Figure 2C). Consistent with this, 
Figure 2D shows that in the mouse as in the human (Figure 1E), 
there is a significant correlation between the heart rate lowering 
effect of ivabradine and the intrinsic heart rate: mice with a low-
er intrinsic heart rate (generally trained) had a blunted response 
to ivabradine. These data are consistent with a downregulation 
of HCN4 and If being the cause of the training-induced brady-
cardia in mice, consistent with our previous study.5
In sinus node biopsies, we measured expression of all 
miRs using next-generation sequencing. Seven hundred and 
fifteen miRs were detected in the sinus node. DeSeq analysis 
showed that 25 miRs were significantly increased >1.8 fold 
and 6 significantly decreased (Figure 2E; Online Table III). 
After applying a 5% Benjamini–Hochberg false discovery rate 
correction, miR-5099, miR-486-3p, miR-423-5p, Let-7d-3p, 
miR-676-3p, miR-181b-5p, and Let-7e-5p were significant-
ly upregulated and miR-10b-5p downregulated (Figure 2E, 
hatched bars). qPCR analysis confirmed the majority of these 
changes (including in miR-423-5p; Figure 2F).
HCN4 Is Target Gene for miR-423-5p
A computational search was conducted (see Online Data 
Supplement) to establish a link between significantly upregulat-
ed miRs and HCN4 downregulation. miRs bind cognate mRNAs 
by imprecise complementary base pairing to specific sequence 
motifs primarily in the 3′-untranslated region (UTR).17 Using the 
widely used algorithms RNA22,18 PITA,19 and TargetScan Mouse 
v7.1,20 we identified putative recognition sites for miR-423-5p 
(Online Figure II) and miR-486-3p (data not shown) within the 
mouse HCN4 3′-UTR sequence. To verify these predicted bind-
ing sites and experimentally establish HCN4 as a genuine tar-
get, we fused the HCN4 3′-UTR to a luciferase reporter gene 
(pHCN4-3′ UTR) and determined luciferase activity in H9c2 
cells cotransfected with pHCN4-3′ UTR and synthetic precur-
sors to miR-423-5p and miR-486-3p. Additionally, we included 
miR-1 and miR-27a in this analysis as we have previously found 
miR-1 to be upregulated in the sinus node of the trained mouse 
and rat,5 and all computational tools used indicated the presence 
of a highly conserved binding site for miR-27a. All miRs tested 
significantly supressed luciferase activity relative to a control 
(scrambled) miR, although suppression was modest on transfec-
tion with miR-1 and miR-486-3p (34%; data not shown) com-
pared with miR-423-5p (Figure 3A). Surprisingly, miR-27a only 
produced a small suppression of luciferase activity (Figure 3A).
We selected miR-423-5p for further study because it was 
predicted to target HCN4, it was significantly upregulated us-
ing both next-generation sequencing (2.8-fold increase above 
baseline) and qPCR (8.1-fold increase above baseline), and it 
produced the largest suppression of luciferase activity among 
the miRs tested. We observed a dose-dependent effect of miR-
423-5p on luciferase activity of pHCN4-3′ UTR (Figure 3C). 
Furthermore, mutation of predicted miR-423-5p binding se-
quences in the HCN4 3′- UTR (Figure 3B) abolished the effect 
of miR-423-5p on reporter expression (Figure 3C). These find-
ings demonstrate a specific interaction between miR-423-5p 
and HCN4, and the predicted recognition elements identified 
in the HCN4 3′ -UTR contribute to this. Both HCN4 mRNA 
and intrinsic heart rate showed a significant inverse correla-
tion with expression of miR-423-5p (Figure 3D and 3E). 
Linear regression analysis showed that the sinus node expres-
sion level of miR-423-5p explained 68% of the variation in 
HCN4 (Figure 3D; R2
 = 0.68) and 46% of the variation in spon-
taneous beating rate of the sinus node (Figure 3E; R2 = 0.46). 
Upregulation of miR-423-5p appeared to be restricted to the 
trained sinus node—basal expression of miR-423-5p was low-
er in the atrium and ventricle and was unaltered by training 
(Figure 3F). After 2 weeks of detraining (after 4 weeks of train-
ing), there was a partial restoration of miR-423-5p (Figure 3G).
Although Figure 3A through 3C shows that miR-423-5p 
targets HCN4, it is possible that it has other targets. Previously, 
miR-423-5p has been reported to cause apoptosis of cardio-
myocytes,21–23 and we performed the TUNEL (terminal de-
oxynucleotidyl transferase  dUTP nick-end labeling) assay to 
assess apoptosis. However, we observed few apoptotic cells 
in the sinus node, and there was no significant difference in 
the number in sedentary and trained mice (Online Figure III).
Training-Induced Downregulation of HCN4 and 
If and Resulting Sinus Bradycardia Is result of 
Upregulation of miR-423-5p
We hypothesized that the training-induced upregulation of 
miR-423-5p results in the downregulation of HCN4 and, 
Figure 2 Continued. (measured by next generation sequencing) in sinus node of mice. Ratio of miR expression in trained mice to 
expression in sedentary mice shown on logarithmic scale. Hatched bars indicate significant differences after Benjamini–Hochberg false 
discovery rate (FDR) correction (P<0.05). Data obtained from 3 pooled RNA samples per group (n=2/2). F, Verification of training-induced 
changes in miRs by quantitative real-time reverse transcription polymerase chain reaction (qPCR). Expression shown in sedentary and 
trained mice (n=6/7–9). *Significant difference between sedentary and trained data (P<0.05).
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Figure 3. HCN4 (hyperpolarization-activated cyclic nucleotide gated channel 4) is a target gene for miR-423-5p. A, Luciferase 
reporter assay showing post-transcriptional repression of HCN4 by miRs. H9C2 cells were cotransfected with precursor miR and 
3′-UTR of HCN4 cloned into expression vector downstream of luciferase gene. Luciferase activity is shown 24 h after cotransfection 
with different miRs, including a control (scrambled) miR. n=3 batches of cells with 4 to 5 replicates/batch. B, Predicted miR-423-5p 
binding sites in HCN4 3′-UTR and corresponding sequence of mutant HCN4 3′-UTR tested. C, Luciferase reporter assay showing 
dose-dependent repression of HCN4 by miR-423-5p and loss of repression by mutation of HCN4 3′-UTR. Luciferase activity is 
shown 24 h after cotransfection with different amounts of wild-type or mutant miR-423-5p. n=3 batches of cells with 4 replicates/
batch. D, Relationship between HCN4 mRNA and log miR-423-5p in sedentary and trained mice (n=5/5). E, Relationship between 
the heart rate measured in vitro in the isolated sinus node and log miR-423-5p in sedentary and trained mice (n=6/7). In D and E, 
data fit by linear regression; best fit line, 95% confidence limits, and R2 and P values are shown. F, Expression of miR-423-5p (Continued )
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consequently, a lower heart rate. To test this, miR-423-5p was 
knocked down in vivo via 3 daily intraperitoneal injections of 
cholesterol-conjugated anti-miR-423-5p (anti-miR) in seden-
tary mice and in trained mice at day 25 to 27 of the swimming 
protocol (Figure 4A). Administered in this way, cholesterol-
conjugated anti-miR has previously been documented to be 
highly effective in knocking down target miR in the heart with 
long-lasting efficacy under in vivo conditions.6 At day 28, that 
is, 3 days after the first administration, qPCR analysis showed 
a dramatic reduction in the level of miR-423-5p (Figure 4B). A 
separate study demonstrated that the suppressive effect of the 
anti-miR on miR-423-5p persisted for up to 3 weeks after ad-
ministration (Online Figure IV). Remarkably, the anti-miR abol-
ished or blunted the training-induced bradycardia: it restored 
the heart rate measured in vivo and in vitro (isolated sinus node) 
to or toward the pretraining level (Figure 4C). Intriguingly, the 
anti-miR did not alter the heart rate in vivo in sedentary ani-
mals, despite successful knockdown of miR-423-5p (Online 
Figure V); the effect of the anti-miR was, therefore, restricted 
to the trained mouse. Western blot analysis demonstrated that 
the anti-miR completely restored total HCN4 protein in the si-
nus node (level in anti-miR-treated mice was 2.1× greater than 
that in vehicle-treated sedentary mice; Figure 4D). The effect of 
anti-miR on If was assessed in vitro by pharmacological block 
of If with 2 mmol/L Cs+ in the isolated sinus node (Figure 4E).24 
Two mmol/L Cs+ produced a smaller decrease in spontaneous 
beating rate in trained animals (indicative of reduction in If), 
and this effect was reversed by the anti-miR, indicating restora-
tion of If by the anti-miR (Figure 4E). Whole cell patch clamp 
recordings from isolated sinus node cells confirmed this: the 
density of If was reduced in trained mice, and it was almost fully 
restored in trained mice treated with the anti-miR (Figure 4F). 
In summary, the anti-miR restored total HCN4 protein (trans-
membrane fraction of which is responsible for If) beyond the 
control level, almost fully restored If, fully restored responsive-
ness to Cs+ (indirect measure of If), almost fully restored the 
intrinsic heart rate (arguably set by If) measured in the isolated 
sinus node, and fully restored the heart rate measured in vivo 
(again arguably set by If). Total HCN4 protein may have been 
restored beyond the control level because of an increase in the 
amount of protein being trafficked to the membrane. It is not 
known why heart rate in vivo was fully restored, whereas If was 
only partially restored—it is possible that there is an additional 
mechanism in operation. A control (nontargeting) anti-miR did 
not restore If (Online Figure VI). The heart weight:body weight 
ratio and various ECG parameters were largely unaffected by 
the anti-miR (Online Figure VII).
Control of miR-423-5p in the Trained Sinus Node
miR-423 is located in the first intron of its host gene, 
NSRP1, and both are transcribed in the same sense direction 
(Figure 5A). Therefore, it is possible that they are coregu-
lated and share regulatory (promoter) elements, as has been 
shown previously for intronic miRs.25,26 qPCR confirmed that 
NSRP1 mRNA was significantly upregulated in the sinus 
node of trained mice (Figure 5B). A bioinformatics search 
using MatInspector revealed transcription factors that could 
potentially bind to the promoter region of NSRP1. The ex-
pression of the 88 top predicted transcription factors in the 
sinus node was investigated using qPCR—15 were signifi-
cantly upregulated and 2 significantly downregulated after 
training (Figure 5C). Of these 17, Nkx2.5 (data for Nkx2.5 
shown in more detail in Figure 5D) was the most promising 
on the basis that it was upregulated (therefore, potentially ex-
plaining the upregulation of NSRP1), it is an important car-
diac transcription factor, it is known to work in consort with 
other transcription factors (Foxp1, Stat3, and Tbx527–29) that 
were also upregulated in the sinus node with athletic training 
(Figure 5C), it represses the working phenotype in the sinus 
node, and most importantly it has previously been shown that 
upregulation is associated with sick sinus disease and sinus 
bradycardia.30 Although Nkx2.5 is thought not to be expressed 
in the adult sinus node, we observed substantial expression 
of both Nkx2.5 mRNA and protein in the sinus node even in 
the case of the sedentary mouse (Online Figure X; see Online 
Data Supplement for further discussion). Predicted Nkx2.5 
binding sites on NSRP1 are given in Online Figure VIII. To 
verify NSRP1 as a target of Nkx2.5, we fused 2.1 kb of the 
5′ flanking region of NSRP1 (upstream of the transcriptional 
start site) to luciferase and determined luciferase activity in 
H9c2 cells cotransfected with an Nkx2.5 overexpression plas-
mid. Nkx2.5 significantly increased luciferase activity relative 
to vehicle control (Figure 5E). To confirm this finding, Nkx2.5 
was then overexpressed in H9c2 cells. Surprisingly, Nkx2.5 
had little effect on expression of NSRP1 (Online Figure IX), 
but it resulted in a robust increase in miR-423-5p (Figure 5F). 
It is possible that miR-423-5p is one of 20% of intronic miRs 
that are predicted to inhibit expression of their host gene.31 In 
this case, whether Nkx2.5 upregulates both NSRP1 and miR-
423-5p may depend on the precise circumstances. We con-
clude from these data that the upregulation of miR-423-5p in 
the sinus node after training involves an upregulation of the 
transcription factor, Nkx2.5.
Discussion
Our previous work on rodents was the first to attribute exercise 
training–induced bradycardia to the downregulation of HCN4 
and If.5 We now present evidence suggesting this is also the 
case in human athletes. In addition, we show that HCN4 is a 
novel target for post-transcriptional repression by miR-423-5p 
and the training-induced downregulation of HCN4 and If, and 
consequently, the bradycardia is the result of an upregulation 
of Nkx2.5 and consequently miR-423-5p in the sinus node. 
This is the first report of miR-dependent regulation of pace-
making and heart rate.
There is widespread belief that the resting bradycardia in 
athletes is the result of high vagal tone, although vagal tone 
Figure 3 Continued. (measured by quantitative real-time reverse transcription polymerase chain reaction [qPCR]) in atrium and 
ventricle is low and unaltered by training. Expression shown in sinus node, right atrial muscle, and left ventricular muscle from 
sedentary and trained mice (n=5/5/5). Inset, data from left ventricular muscle at magnified scale. G, Expression of miR-423-5p 
(measured by qPCR) in sinus node is partially restored on detraining (right). Expression shown in sinus node of sedentary, trained, and 
detrained mice (n=5/9/5). *Significantly different from control/sedentary data (P<0.05).
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Figure 4. Anti-miR to miR-423-5p reverses training-induced bradycardia and blunts HCN4 (hyperpolarization-activated cyclic 
nucleotide gated channel 4) channel remodeling. A, Time course of exercise training and anti-miR administration. B, Anti-miR 
abolishes training-induced upregulation of miR-423-5p in sinus node. miR-423-5p (determined by quantitative real-time reverse 
transcription polymerase chain reaction [qPCR]) in sinus node of vehicle- or anti–miR-treated sedentary and trained mice shown 
(n=6/5/5/5). C, Anti-miR reverses training-induced bradycardia. Representative ECG traces (recorded from conscious animals) 
from a vehicle-treated sedentary mouse, vehicle-treated trained mouse, and anti–miR-treated trained mouse shown on left and 
mean heart rates (measured in vivo and in isolated sinus node) on right (n=10/12/12 and 9/12/12). D, Anti-miR reverses training-
induced downregulation of HCN4. Western blots using antibodies recognizing HCN4 and actin (housekeeper) proteins for sinus 
node from vehicle-treated sedentary, vehicle-treated trained, and anti-miR-treated trained mice shown as well as mean expression 
level of HCN4 protein (normalized to actin) in the 3 groups (n=5/4/5 with 3 independent replicates per mouse). E, Anti-miR reverses 
training-induced downregulation in contribution of If to pacemaking. Percentage decrease in heart rate (recorded from isolated sinus 
node preparations) on blocking If using 2 mmol/L Cs
+ invehicle-treated sedentary, vehicle-treated trained, and anti-miR-treated 
trained mice shown (n=6/7/4). F, Anti-miR reverses training-induced downregulation in If. Representative If traces (normalized to 
cell capacitance) from vehicle-treated sedentary, vehicle-treated trained, and anti-miR-treated trained mice shown on left and 
mean current–voltage relationships for If from vehicle-treated sedentary (n=47 cells/5 animals), vehicle-treated trained (n=58 cells/4 
animals), and anti-miR-treated trained (n=89 cells/5 animals) mice shown on right. *Significantly different (B–E) or significantly 
different from trained+vehicle data (E; P<0.05).
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has never been directly measured in athletes.32 However, 
critical analysis of the literature does not necessarily support 
this.15,33,34 An increase in heart rate variability in human ath-
letes has been extensively quoted as evidence for high vagal 
tone in athletes.32 However, we have shown from an analysis 
of the underlying biophysics of pacemaking that heart rate 
variability is primarily determined (in an exponential-like 
manner) by heart rate, and the increase in heart rate variability 
in athletes is attributed to the resting bradycardia rather than 
any increase in vagal tone.11 This study has shown that the 
relative bradycardia in human athletes (as compared with the 
heart rate of the control subjects) was still present (and in fact 
was larger) after complete autonomic blockade (Figure 1B). 
The same result (a larger relative bradycardia after autonom-
ic blockade) has been reported by 3 other studies of human 
athletes.15 This suggests that the autonomic nervous system 
is not responsible for the resting bradycardia. Once again, 
many studies of animal models of exercise training show no 
evidence of high vagal tone.15 However, some studies of hu-
man athletes or animal models of exercise training apparently 
Figure 5. Nkx2.5 regulation of miR-423-5p. A, map of NSRP1 gene (solid blocks show exons with introns in between) showing location 
of Nkx2.5 binding sites and intronic location of the miR-423 gene. B, Expression of NSRP1 mRNA in sinus node of sedentary and trained 
mice (n=8/8). C, Significant (P<0.05) training-induced changes in expression of transcription factor transcripts (measured by quantitative 
real-time reverse transcription polymerase chain reaction [qPCR]) in sinus node of mice. Ratio of mRNA expression in trained mice to 
expression in sedentary mice shown (n=6/8). D, Expression of Nkx2.5 mRNA in sinus node of sedentary and trained mice (n=8/8). E, 
Luciferase reporter assay showing activation of NSRP1 transcription by Nkx2.5. H9c2 cells were transfected with 2.1 kb of the 5′ flanking 
region of NSRP1 cloned into expression vector downstream of gene for luciferase. The cells were cotransfected with Nkx2.5; control 
cells were not cotransfected with Nkx2.5. Luciferase activity is shown 48 h after transfection. n=3 independent batches of cells with 4 
replicates/batch. F, Upregulation of miR-423-5p by Nkx2.5. miR-423-5p expression is shown in H9c2 cells not transfected (control) or 
transfected with Nkx2.5.
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show a reduction of the relative bradycardia after autonomic 
blockade, leaving open the possibility that high vagal tone 
does play a role.15,35,36 This is considered further in Discussion 
in the Online Data Supplement. Previously, we showed that 
the reduction of heart rate on blocking If by ivabradine or Cs+ 
is decreased in the trained rodent, and this is attributed to the 
training-induced downregulation of HCN4 and If.5 The corol-
lary of this, as shown in Figure 2D, is that there is a correla-
tion between the effect of ivabradine and the intrinsic heart 
rate of sedentary and trained mice. As shown in Figure 1E, 
the same correlation is observed in sedentary and trained hu-
man subjects. It is, therefore, possible that there is a training-
induced downregulation of HCN4 and If in the human athlete, 
and this is the cause (or at least a contributing cause) of the 
bradycardia.
miR profiling by next-generation sequencing revealed 35 
miRs to be altered by endurance training in the sinus node 
(Figure 2E). Several of these miRs have previously been 
shown to exert regulatory effects in the heart: miR-486-3p, up-
regulated in the sinus node of the trained mice (Figure 2E and 
2F), has previously been shown to be upregulated in the hearts 
of swim-trained mice and involved in the antifibrotic effects of 
exercise37; Let-7e, upregulated in the sinus node of the trained 
mice (Figure 2E and 2F), has previously been shown to have 
an antiarrhythmic effect mediated via a downregulation of the 
β1 adrenergic receptor in myocardial infarction rats38; finally, 
miR-10b-5p, downregulated in the sinus node of the trained 
mice (Figure 2E and 2F), has previously been shown to regu-
late the key cardiac transcription factor Tbx5, known to be 
involved with the cardiac conduction system.39 Previously, the 
plasma level of miR-423-5p has been reported to be elevated 
in heart failure, acute myocardial infarction, stable coronary 
artery disease, and patients undergoing cardiac surgery.40–42 In 
the case of heart failure at least, this is thought to be the result 
of altered myocardial expression.42 In these studies, although 
the source of miR-423-5p may be the myocardium, it is not 
known from what part of the heart it originates. Figure 3F sug-
gests that miR-423-5p is preferentially expressed by the sinus 
node, and this raises the question of whether the sinus node 
is the source of miR-423-5p in heart failure. Paradoxically, 
the sinus node in heart failure is like that in the athlete; there 
is intrinsic sinus bradycardia and a widespread remodeling 
of the sinus node with a downregulation of ion channels.43–45 
miRs are known to function according to a combinatorial cir-
cuitry model, whereby a single miR targets multiple mRNAs 
and several coexpressed miRs may target a single mRNA.46 
While our data suggest a prominent role for miR-423-5p in 
regulating HCN4, we cannot rule out a role for other miRs. 
Ultimately, regulation of heart rate is a complex and dynamic 
process involving acute regulation by the autonomic nervous 
system and longer-term regulation involving changes in ion 
channel expression brought about by transcription factors and, 
as shown for the first time by our study, miRs.
In conclusion, our findings provide new insight into the 
molecular mechanisms underlying the sinus bradycardia in 
athletes, and this may have implications for other conditions in 
which If is dysregulated, for example, heart failure.43 Although 
the changes in the sinus node and sinus bradycardia are well 
tolerated by healthy young athletes, this is not necessarily the 
case in some veteran athletes and the changes manifest as 
pathological sinus node dysfunction—the incidence of pace-
maker implantation in veteran athletes is higher than that in 
nonathletes.2–4 Inhibition of miR-423-5p (especially because 
upregulation of miR-423-5p could be restricted to the sinus 
node; Figure 3F) could be an alternative therapeutic strategy 
to electronic pacemaker implantation for pathological sinus 
node dysfunction seen in some veteran athletes.
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